Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
出版年份 2014 全文链接
标题
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 76, Issue 6, Pages 802-812
出版商
Wiley
发表日期
2014-10-02
DOI
10.1002/ana.24286
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study
- (2014) P. O'Connor et al. NEUROLOGY
- JC virus antibody status underestimates infection rates
- (2013) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
- (2013) Peter Lee et al. JOURNAL OF CLINICAL VIROLOGY
- Changes to anti-JCV antibody levels in a Swedish national MS cohort
- (2013) Clemens Warnke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- JC-virus seroconversion in multiple sclerosis patients receiving natalizumab
- (2013) Olivier Outteryck et al. Multiple Sclerosis Journal
- Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
- (2013) Tomas Olsson et al. Multiple Sclerosis Journal
- HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia
- (2013) K. Masutani et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
- (2013) Eugene O. Major et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sequential changes in the non-coding control region sequences of JC polyomaviruses from the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
- (2012) Kazuo Nakamichi et al. ARCHIVES OF VIROLOGY
- Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy
- (2012) Olivier Outteryck et al. JOURNAL OF NEUROLOGY
- Anti-JCV Antibody Prevalence in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-2 (S41.002)
- (2012) C. Bozic et al. NEUROLOGY
- Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
- (2012) A. K. Trampe et al. NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
- (2011) Carmen Bozic et al. ANNALS OF NEUROLOGY
- High Levels of Antibodies Against Merkel Cell Polyomavirus Identify a Subset of Patients With Merkel Cell Carcinoma With Better Clinical Outcome
- (2011) Antoine Touzé et al. JOURNAL OF CLINICAL ONCOLOGY
- Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer
- (2011) Diana V. Pastrana et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- BK virus antibody titers and intensity of infections after renal transplantation
- (2008) Daniel L. Bohl et al. JOURNAL OF CLINICAL VIROLOGY
- Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology
- (2008) Rainer Gosert et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now